# Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer

> **NCT04631445** · NA · COMPLETED · sponsor: **Translational Drug Development** · enrollment: 32 (actual)

## Conditions studied

- Metastatic Pancreatic Ductal Adenocarcinoma

## Interventions

- **OTHER:** Ketogenic Diet

## Key facts

- **NCT ID:** NCT04631445
- **Lead sponsor:** Translational Drug Development
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-02
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04631445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04631445, "Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04631445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*